These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

46 related articles for article (PubMed ID: 10177944)

  • 1. From rationing to rational: the evolving status of NICE.
    Minhas R; Patel KC
    J R Soc Med; 2008 Sep; 101(9):436-42. PubMed ID: 18779244
    [No Abstract]   [Full Text] [Related]  

  • 2. Handling uncertainty in economic evaluations of healthcare interventions.
    Briggs AH; Gray AM
    BMJ; 1999 Sep; 319(7210):635-8. PubMed ID: 10473486
    [No Abstract]   [Full Text] [Related]  

  • 3. Economic Notes: opportunity cost.
    Palmer S; Raftery J
    BMJ; 1999 Jun; 318(7197):1551-2. PubMed ID: 10356019
    [No Abstract]   [Full Text] [Related]  

  • 4. Prognosis without treatment as a modifier in health economic assessments.
    Camidge R; Walker A; Oliver JJ; Nussey F; Maxwell S; Jodrell D; Webb DJ
    BMJ; 2005 Jun; 330(7504):1382-4. PubMed ID: 15947403
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of economic evaluation in setting priorities for elective surgery.
    Coast J
    Health Policy; 1993 Aug; 24(3):243-57. PubMed ID: 10171517
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Creativity and sacrifice: two sides of the coin. A reply to David Seedhouse.
    Farrar S; Donaldson C; Macphee S; Walker A; Mapp T
    Health Care Anal; 1997 Dec; 5(4):306-9. PubMed ID: 10177944
    [No Abstract]   [Full Text] [Related]  

  • 7. Street-level bureaucrats? heart disease, health economics and policy in a primary care group.
    McDonald R
    Health Soc Care Community; 2002 May; 10(3):129-35. PubMed ID: 12121248
    [No Abstract]   [Full Text] [Related]  

  • 8. On being NICE in the UK: guidelines for technology appraisal for the NHS in England and Wales.
    Birch S; Gafni A
    Health Econ; 2002 Apr; 11(3):185-91. PubMed ID: 11921316
    [No Abstract]   [Full Text] [Related]  

  • 9. The inescapable prejudice of health economics: a reply to Farrar, Donaldson, Macphee, Walker and Mapp.
    Seedhouse D
    Health Care Anal; 1997 Dec; 5(4):310-4. PubMed ID: 10177945
    [No Abstract]   [Full Text] [Related]  

  • 10. Rationing and the health authority.
    Hope T; Hicks N; Reynolds DJ; Crisp R; Griffiths S
    BMJ; 1998 Oct; 317(7165):1067-9. PubMed ID: 9774299
    [No Abstract]   [Full Text] [Related]  

  • 11. Decision making in quasi-markets: a pedagogic analysis.
    Jones PR; Cullis JG
    J Health Econ; 1996 Apr; 15(2):187-208. PubMed ID: 10159109
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessing community values in health care: is the 'willingness to pay' method feasible?
    Donaldson C; Farrar S; Mapp T; Walker A; Macphee S
    Health Care Anal; 1997 Mar; 5(1):7-29. PubMed ID: 10166053
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tautology and value: the flawed foundations of health economics.
    Seedhouse D
    Health Care Anal; 1997 Mar; 5(1):1-5. PubMed ID: 10166047
    [No Abstract]   [Full Text] [Related]  

  • 14. Value for money? A contingent valuation study of the optimal size of the Swedish health care budget.
    Eckerlund I; Johannesson M; Johansson PO; Tambour M; Zethraeus N
    Health Policy; 1995 Nov; 34(2):135-43. PubMed ID: 10153482
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.